Gene expression profiling of adrenal cortical tumors by cDNA macroarray analysis. Results of a preliminary study

Allolio, 2004, Management of adrenocortical carcinoma, Clin. Endocrinol. (Oxf.), 60, 273, 10.1046/j.1365-2265.2003.01881.x Dackiw, 2001, Adrenal cortical carcinoma, World J. Surg., 25, 914, 10.1007/s00268-001-0030-7 Weiss, 1989, Pathologic features of prognostic significance in adrenocortical carcinoma, Am. J. Surg. Pathol., 13, 202, 10.1097/00000478-198903000-00004 Harrison, 1999, Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection, Arch. Surg., 134, 181, 10.1001/archsurg.134.2.181 Giordano, 2003, Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis, Am. J. Pathol., 162, 521, 10.1016/S0002-9440(10)63846-1 Haak, 1993, Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma, Br. J. Cancer, 68, 151, 10.1038/bjc.1993.304 Reincke, 1994, P53 mutations in human adrenocortical neoplasm: immmunohistochemical and molecular studies, J. Clin. Endocrinol. Metab., 78, 790, 10.1210/jc.78.3.790 Wachenfeld, 2001, Discerning malignancy in adrenocortical tumors: are molecular markers useful?, Eur. J. Endocrinol., 145, 335, 10.1530/eje.0.1450335 Goldblum, 1993, Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms, Mod. Pathol., 6, 663 Iino, 1997, DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas, Mod. Pathol., 10, 901 Stojadinovic, 2002, Adrenocortical carcinoma: clinical, morphologic and molecular characterization, J. Clin. Oncol., 20, 941, 10.1200/JCO.20.4.941 Stojadinovic, 2003, Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis, Mod. Pathol., 16, 742, 10.1097/01.MP.0000081730.72305.81 Bernini, 2002, Apoptosis control and proliferation marker in human normal and neoplastic tissues, Br. J. Cancer, 86, 1561, 10.1038/sj.bjc.6600287 Kanauchi, 2002, Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance, Surgery, 132, 1021, 10.1067/msy.2002.128616 Brown, 1999, Exploring the new world of the genome with DNA microarrays, Nat Gen, 21, 33, 10.1038/4462 Lewis, 2001, Unlocking the archive—gene expression in paraffin-embedded tissue, J. Pathol., 195, 66, 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F Tsunoda, 2003, Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysis, Intern J Oncol, 3, 49 Delpuech, 2002, Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma, Oncogene, 21, 2926, 10.1038/sj.onc.1205392 Zhao, 2002, Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors, Genes Chrom Cancer, 34, 48, 10.1002/gcc.10035 Kakajima, 2003, Gene expression screening using a cDNA macroarray to clarify the mechanism of peritoneal dissemination of pancreatic cancer, Surg. Today, 33, 190, 10.1007/s005950300042 Musholt, 2003, RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hurtle cell carcinomas?, Surgery, 134, 881, 10.1016/j.surg.2003.08.003 Hu, 2001, Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1 and CDC25B genes in ESCC, Clin. Cancer Res., 7, 2213 Kim, 2003, Differential gene expression analysis using paraffin-embedded tissues after laser microdissection, J. Cell. Biochem., 90, 998, 10.1002/jcb.10680 Soonmyung, 2005, Technology Insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer, Nat Clin Pract Oncol, 2, 246, 10.1038/ncponc0171 Pignatelli, 2003, Immunohistochemical study of Heat Shock Proteins 27, 60 and 70 in normal human adrenal and in adrenal tumors with suppressed ACTH production, Microsc. Res. Tech., 61, 315, 10.1002/jemt.10341 Cornford, 2000, Heat shock protein expression independently predicts clinical outcome in prostate cancer, Cancer Res., 60, 7099 Sherr, 1996, Cancer cell cycles, Science, 274, 1672, 10.1126/science.274.5293.1672 Swanson, 2004, Cell-cycle targeted therapies, Lancet Oncol, 5, 27, 10.1016/S1470-2045(03)01321-4 Vogt, 2001, Jun, the oncoprotein, Oncogene, 20, 2365, 10.1038/sj.onc.1204443 Armelin, 1996, Regulation of growth by ACTH in the Y-1 line of mouse adrenocortical cells, Endocr. Res., 22, 373, 10.1080/07435809609043721 Baudin, 2002, Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma, Ann. Oncol., 13, 1806, 10.1093/annonc/mdf291